Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal

Nutrition

Volumn 28, Issue 11-12, 2012, Pages 1115-1121

  Maki, Kevin C ^a   Gibson, Glenn R ^b   Dickmann, Robin S ^c   Kendall, Cyril W C ^d,f   Chen, C Y Oliver ^e   Costabile, Adele ^b   Comelli, Elena M ^d   McKay, Diane L ^e   Almeida, Nelson G ^c   Jenkins, David ^d   Zello, Gordon A ^f   Blumberg, Jeffrey B ^e  

^a Biofortis Provident Clinical Research   (United States)

^b UNIVERSITY OF READING   (United Kingdom)

^c KELLOGG COMPANY   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e TUFTS UNIVERSITY   (United States)

^f UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Arabino xylan oligosaccharide; Bifidobacteria; Cereals; Ferulic acid; Prebiotics

Indexed keywords

ARABINO XYLAN OLIGOSACCHARIDE; ARABINOXYLAN; FERULIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOPROSTANE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARA CRESOL; PHENOL DERIVATIVE; PREBIOTIC AGENT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIFIDOBACTERIUM; BLOOD ANALYSIS; BLOOD LEVEL; CEREAL; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFECATION HABIT; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FECES MICROFLORA; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; WHEAT BRAN;

ADULT; AGED; BIFIDOBACTERIUM; BREAKFAST; CEREALS; COHORT STUDIES; COUMARIC ACIDS; CROSS-OVER STUDIES; DIETARY FIBER; DIGESTION; DOUBLE-BLIND METHOD; FECES; FEMALE; FOOD, FORTIFIED; HUMANS; ILLINOIS; MALE; MIDDLE AGED; OLIGOSACCHARIDES; PLANT EXTRACTS; TRITICUM; XYLANS;

TRITICUM AESTIVUM;

EID: 84867220028     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.02.010     Document Type: Article

References (48)

1. Serino M., Luche E., Chabo C., Amar J., Burcelin R. Intestinal microflora and metabolic diseases. Diabetes Metab 2009, 35:262-272.
2. Colonic microbiota. Nutrition and health 1999, Kluwer Academic Publishers, London. G.R. Gibson, M.B. Roberfroid (Eds.).
3. Steer T., Carpenter H., Tuohy K., Gibson G.R. Perspectives on the role of the human gut microbiota in health and disease and its modulation by pro- and prebiotics. Nutr Res Rev 2001, 13:229-254.
4. Fuller R., Gibson G.R. Modification of the intestinal microflora using probiotics and prebiotics. Scand J Gastroenterol 1997, 32:28-31.
5. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989, 66:365-378.
6. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995, 125:1401-1412.
7. Tuohy K.M., Kolida S., Lustenberger A.M., Gibson G.R. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructooligosaccharides-a human volunteer study. Br J Nutr 2001, 86:341-348.
8. Lu Z.X., Gibson P.R., Muir J.G., Fielding M., O'Dea K. Arabinoxylan fiber from a by-product of wheat flour processing behaves physiologically like a soluble, fermentable fiber in the large bowel of rats. J Nutr 2000, 130:1984-1990.
9. Broekaert W.F., Courtin C.M., Verbeke K., van de Wiele T., Verstraete W., Delcour J.A. Prebiotic and other health-related effects of cereal-derived arabinoxylans, arabinoxylan-oligosaccharides, and xylooligosaccharides. Crit Rev Food Sci Nutr 2011, 51:178-194.
10. Cloetens L., De Preter V., Swennen K., Broekaert W., Courtin C.M., Delcour J.A., et al. Dose-response effect of arabinoxylooligosaccharides on gastrointestinal motility and on colonic bacterial metabolism in healthy volunteers. J Am Coll Nutr 2008, 27:512-518.
11. Cloetens L., Broekaert W.F., Delaedt Y., Ollevier F., Courtin C.M., Delcour J.A., et al. Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study. Br J Nutr 2010, 103:703-713.
12. Katapodis P., Vardakou M., Kalogeris E., Kekos D., Macris B.J., Christakopoulos P. Enzymic production of a feruloylated oligosaccharide with antioxidant activity from wheat flour arabinoxylan. Eur J Nutr 2003, 42:55-60.
13. Daims H., Stoecker K., Wagner M. Fluorescence in situ hybridization for the detection of prokaryotes. Molecular microbial ecology 2005, 213-239. Garland Science, Abingdon, UK. A.M. Osborn, C.J. Smith (Eds.).
14. Shimotoyodome A., Yajima N., Suzuki J., Tokimitsu I. Effects of coingestion of different fibers on fecal excretion and cecal fermentation in rats. Nutr Res 2005, 25:1085-1096.
15. Broderick G.A., Kang J.H. Automated simultaneous determination of ammonia and total amino acids in ruminal fluid and in vitro media. J Dairy Sci 1980, 63:64-75.
16. Stein J., Kulemeier J., Lembcke B., Caspary W.F. Simple and rapid method for determination of short-chain fatty acids in biological materials by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 1992, 576:53-61.
17. van Eijk H.M., Bloemen J.G., Dejong C.H. Application of liquid chromatography-mass spectrometry to measure short chain fatty acids in blood. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:719-724.
18. Singleton V.L., Orthofer R., Lamuela-Raventós R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol 1999, 299:152-178.
19. De Smet R., David F., Sandra P., Van Kaer J., LeSaffer G., Dhondt A., et al. A sensitive HPLC-method for the quantification of free and total p-cresol in patients with chronic renal failure. Clin Chim Acta 1998, 278:1-21.
20. Walter M.F., Blumberg J.B., Dolnikowski G.G., Handelman G.J. Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy. Anal Biochem 2000, 280:73-79.
21. Ahotupa M., Ruutu M., Mäntylä E. Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin Biochem 1996, 29:139-144.
22. Hu M.L. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994, 233:380-385.
23. Jentzsch A.M., Bachmann H., Fürst P., Biesalski H.K. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996, 20:251-256.
24. Sallis J.F., Haskell W.L., Wood P.D., Fortmann S.P., Rogers T., Blair S.N., et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 1985, 121:91-106.
25. Ou B., Hampsch-Woodill M., Prior R.L. Development and validation of an improved oxygen radial absorbance capacity assay using fluorescein as the fluorescent probe. J Agric Food Chem 2001, 49:4619-4629.
26. Benzie I.F.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of " antioxidant power" : the FRAP assay. Anal Biochem 1996, 239:70-76.
27. Chen C.-Y., Milbury P.E., Lapsley K., Blumberg J.B. Flavonoids from almond skins are bioavailable and act synergistically with vitamins C and E to enhance hamster and human LDL resistance to oxidation. J Nutr 2005, 135:1366-1373.
28. Shapiro S.S., Wilk M.B. An analysis of variance test for normality (complete samples). Biometrika 1965, 52:591-611.
29. van Craeyveld V., Swennen K., Dornez E., van de Wiele T., Marzorati M., Verstraete W., et al. Structurally different wheat-derived arabinoxylooligosaccharides have different prebiotic and fermentation properties in rats. J Nutr 2008, 138:2348-2355.
30. Saulnier D.M., Kolida S., Gibson G.R. Microbiology of the human intestinal tract and approaches for its dietary modulation. Curr Pharm Des 2009, 15:1403-1414.
31. Eeckhaut V., van Immerseel F., Dewulf J., Pasmans F., Haesebrouck F., Ducatelle R., et al. Arabinoxylooligosaccharides from wheat bran inhibit Salmonella colonization in broiler chickens. Poult Sci 2008, 87:2329-2334.
32. Hopkins M.J., Sharp R., Macfarlane G.T. Variation in human intestinal microbiota with age. Dig Liver Dis 2002, 34:S12-S18.
33. McOrist A.L., Miller R.B., Bird A.R., Keogh J.B., Noakes M., Topping D.L., Conlon M.A. Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch. J Nutr 2011, 141:883-889.
34. Weaver G.A., Krause J.A., Miller T.L., Wolin M.J. Cornstarch fermentation by the colonic microbial community yields more butyrate than does cabbage fiber fermentation; cornstarch fermentation rates correlate negatively with methanogenesis. Am J Clin Nutr 1992, 55:70-77.
35. JuŚkiewicz J., Milala J., Jurgoński A., Król B., Zduńczyk Z. Consumption of polyphenol concentrate with dietary fructo-oligosaccharides enhances cecal metabolism of quercetin glycosides in rats. Nutrition 2011, 27:351-357.
36. Cummings J.H., Gibson G.R., Macfarlane G.T. Quantitative estimates of fermentation in the hind gut of man. Acta Vet Scand Suppl 1989, 86:76-82.
37. Macfarlane G.T., Gibson G.R., Cummings J.H. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 1992, 72:57-64.
38. Delzenne N.M., Kok N. Effects of fructans-type prebiotics on lipid metabolism. Am J Clin Nutr 2001, 73(suppl). 456S-8.
39. Forcheron F., Beylot M. Long-term administration in inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans. Metabolism 2007, 56:1093-1098.
40. Ooi L.G., Liong M.T. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 2010, 11:2499-2522.
41. Andersson U., Rosén L., Ostman E., Ström K., Wierup N., Björck I., Holm C. Metabolic effects of whole grain wheat and whole grain rye in the C57BL/6J mouse. Nutrition 2010, 26:230-239.
42. Davidson M.H., Maki K.C. Effects of dietary inulin on serum lipids. J Nutr 1999, 129. 1474S-7.
43. Luo J., van Yperselle M., Rizkalla S.W., Rossi F., Bornet F.R.J., Slama G. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr 2000, 130:1572-1577.
44. Wong J.M., Kendall C.W., de Souza R., Emam A., Marchie A., Vidgen E., et al. The effect on the blood lipid profile of soy foods combined with a prebiotic: a randomized controlled trial. Metabolism 2010, 59:1331-1340.
45. Jenkins D.J., Wolever T.M., Jenkins A., Brighenti F., Vuksan V., Rao A.V., et al. Specific types of colonic fermentation may raise low-density-lipoprotein-cholesterol concentrations. Am J Clin Nutr 1991, 54:141-147.
46. Wolever T.M., Brighenti F., Royall D., Jenkins A.L., Jenkins D.J. Effect of rectal infusion of short chain fatty acids in human subjects. Am J Gastroenterol 1989, 84:1027-1033.
47. Mai V., Draganov P.V. Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J Gastroenterol 2009, 15:81-85.
48. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136:65-80.